Pharma & Biotech
-
Class-Action Suit Against Malvern Pharma Giant Refiled as ‘Bucks County v. Endo’
The Bucks County Employees’ Retirement Fund is now the lead plaintiff in a federal securities class action case against Malvern-based pharma giant Endo International plc. The case’s tactical swich was covered in the Bucks Local News. Two factors caused the reshuffle: Dissatisfaction with the prior lead plaintiff and counsel The reality that the potential $800,000 loss to the fund outweighs the exposure of every other plaintiff The lawsuit alleges that Endo…
-
ESPN: Strokes of Genius: Abington Olympic Gold-Medalist Rower and Her mRNA-Expert Mom Float to the Top of Their Careers
For Susan Francia, a two-time Olympic gold medalist in rowing and daughter of newly famous Abington scientist Dr. Katalin Kariko, hard work was always a part of life, she wrote for ESPN. She was taught by her mother that if she embraced hard work, it would bring her rewards in life. This philosophy turned true…
-
Medical Device Company in Wayne Raises $9 Million to Expand ‘Commercial Efforts’
Wayne-based Cagent Vascular has received a $9 million investment from Sectoral Asset Management to accelerate the commercialization of its lead product, writes John George for the Philadelphia Business Journal. Following the investment, Marc-Andre Marcotte, a partner and COO at Canada-based Sectoral, has joined Cagent’s board of directors. Cagent, founded seven years ago, develops next-generation angioplasty…
-
Abington Scientist/COVID-19 Vaccine Researcher Sees Great Potential in mRNA Technology
While even the majority of scientists working on mRNA vaccines for COVID-19 were shocked by its effectiveness, Katalin Karikó, an Abington biochemist and one of the pioneers of mRNA technology research, did not expect anything less, writes Stephen Buranyi for WIRED. “There was no nail biting,” she said. “I expected the vaccines to be very…
-
Newtown Pharma Manufacturer Faces Food and Drug Administration Fraud Charges
The U.S. Attorney’s Office filed charges against KVK-Tech, Inc., a generic drug manufacturer in Newtown, reports John George for the Philadelphia Business Journal. The federal government alleges that the company — and two of its leaders — distributed unapproved drugs, sought to mislead the Food and Drug Administration (FDA), and concealed safety and efficacy details. It was also charged with one count…
-
Healthcare Marketing Firm Notes Yet One More Business Staple Changed Forever by the Pandemic
Once upon a time, pharmaceutical sales were, at their core, 1:1 interactions: Rep made an appointment with physician Showed up onsite Extolled the virtues of a particular medication or treatment Left a good impression, sealed by a firm handshake Hoped that the recommendation would increasingly find its way onto prescription pads across the practice Stephen Ross,…
-
Doylestown Medical Device Company Sells More than a Million Syringes, Easing Those Aching Knees
Syringe sales of its TriVisc syringes bolstered the bottom line of Doylestown’s OrthogenRx, Inc., throughout the first half of 2021. The medical device company doesn’t supply them for COVID-19 vaccinations. Its product line instead focused on the 14 million U.S. adults with osteoarthritic knees. OrthogenRx used multiple sales channels and partnerships to market its syringes. Their uses include prescribed three-week injections of…
-
Trevose-Headquartered Strongbridge Biopharma Acquired by Xeris for $267 Million
Strongbridge Biopharma of Trevose has been acquired by Chicago’s Xeris Pharmaceutical for $267 million, reports John George in the Philadelphia Business Journal. Xeris will own 60 percent or so of the combined business entities, with the remaining 40 percent remaining under Stonebridge ownership. Xeris has developed a proprietary formulation technology platform for ready-to-use injectable drug formulations. It markets Gvoke, a treatment for…
-
Chief Executive Magazine Names Merck’s Kenneth Frazier CEO of the Year
Kenneth Frazier, CEO of Merck, the pharmaceutical giant with sizable operations in West Point, has been named CEO of the Year by Chief Executive magazine, writes Alex Keown for BioSpace. Upper Gwynedd-based Frazier, who will retire from his role at the end of next month, was selected by an independent committee for the prestigious title.…
-
Hatboro-Horsham Seniors Completed Research That Will Be Used by Atrin Pharmaceuticals
Despite doing most of their internship over Zoom, rising Hatboro-Horsham seniors Sarah Shegogue and Allyson Suman have successfully completed research that will be used by Atrin Pharmaceuticals in the future, according to a staff report from the Montgomery News. The pair worked on research related to Wee-1, a kinase or enzyme that is involved in…
Founding Partners
Advertisement
Affiliate Partners
